62 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
19 Apr 24
Current report (foreign)
6:12am
by market).1,2 Vedolizumab SC has been granted marketing authorization in the United States, European Union and more than 50 countries. Vedolizumab IV has … been granted marketing authorization in more than 70 countries, including the United States and European Union. Globally, vedolizumab IV and SC have
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
is approved in the European Union (EU), Israel, Switzerland, Serbia, United Kingdom and Japan based on positive data from the previously completed ADMIRE-CD … in the European Union (EU) for previously treated mCRC. The MAA for fruquintinib includes results from the global Phase 3 FRESCO-2 clinical trial along
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
is approved in the European Union (EU), Israel, Switzerland, Serbia, United Kingdom and Japan based on positive data from the previously completed … selective and potent inhibitor of VEGFR -1, -2 and -3 approved in the European Union (EU) for previously treated metastatic CRC. The MAA for fruquintinib
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
18 Oct 23
Current report (foreign)
6:20am
results of the study will be presented at a future medical meeting or published in a peer-reviewed journal. Alofisel is approved in the European Union … It is the first allogeneic stem cell therapy to receive centralized marketing authorization approval in the European Union, and the first expanded human
6-K
TAK
Takeda Pharmaceutical Co
28 Sep 23
Current report (foreign)
6:17am
(SC) administration (approvals vary by market).1,2 Vedolizumab SC has been granted marketing authorization in the United States, European Union … authorization in more than 70 countries, including the United States and European Union. Globally, vedolizumab IV and SC have more than one million patient
6-K
4dm 1gdlkn30
1 Aug 23
Current report (foreign)
6:10am
6-K
EX-99.1
8ywwe8y9lv7pne m1
6 Jul 23
Current report (foreign)
6:18am
6-K
EX-99.1
yvo4oq7jud8qgkm39p
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
tgwobbwgsadc0ftah
30 May 23
Current report (foreign)
6:11am
6-K
e40dngxq tf8ezgckd
8 Dec 22
Current report (foreign)
6:46am
6-K
z1awqrz4pabjvgj2 ph
4 Nov 22
Current report (foreign)
6:01am
6-K
EX-99.1
2vssn
23 Aug 22
Current report (foreign)
6:13am
6-K
q4chy2zp
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
ex50pzq0
31 May 22
Current report (foreign)
6:07am
6-K
nvl3bvnv
10 Feb 22
Current report (foreign)
6:03am
6-K
mxx 4cwfn
5 Nov 21
Current report (foreign)
6:02am
6-K
forrdj8lmo0q76 rb55
6 Aug 21
Current report (foreign)
6:06am